Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Functional evaluation of Dent's disease-causing mutations: implications for ClC-5 channel trafficking and internalization.
Ludwig M, Doroszewicz J, Seyberth HW, Bökenkamp A, Balluch B, Nuutinen M, Utsch B, Waldegger S.
???displayArticle.abstract???
ClC-5 is a member of the ClC family of voltage-gated chloride channels. Loss-of-function mutations of its corresponding gene (CLCN5) cause Dent's disease, an X-linked kidney disorder, characterized by low-molecular weight proteinuria, hypercalciuria, nephrocalcinosis/nephrolithiasis, and progressive renal failure. Here, we examined the effect of different mutations on function and cellular trafficking of the recombinant protein. Mutant CLCN5 cDNAs were generated by site directed mutagenesis for two premature stop codon variants (R347X and M517IfsX528), and several missense mutations (C221R, L324R, G462 V, and R516 W). We also tested L521R (instead of L521RfsX526 observed) and mutants G506E and R648X (previously reported by others). After heterologous expression in Xenopus oocytes, ClC-5 channel activity and surface expression were determined by two-electrode voltage-clamp analysis and ClC-5 surface ELISA, respectively. Except for the R516 W and R648X variants, none of the mutated proteins induced functional chloride currents or reached the plasma membrane. This is readily understandable for the truncation mutations. Yet, the tested missense mutations are distributed over different transmembrane regions, implying that correct channel structure and orientation in the membrane is not only a prerequisite for proper ClC-5 function but also for Golgi exit. Interestingly, the R648X mutant although functionally compromised, displayed a significant increase in surface expression. This finding might be explained by the deletion of a ClC-5 carboxy-terminal PY-like internalization signal, which in turn impairs channel removal from the membrane. Our observations further imply that recruitment of ClC-5 to alternative routes (plasma membrane or early endosomes) in the trans-Golgi network is mediated via different signal sequences.
Akuta,
Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis.
1997, Pubmed
Akuta,
Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis.
1997,
Pubmed Attree,
The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase.
1992,
Pubmed Bateman,
The structure of a domain common to archaebacteria and the homocystinuria disease protein.
1997,
Pubmed Bosio,
A familial syndrome due to Arg648Stop mutation in the X-linked renal chloride channel gene.
1999,
Pubmed Carr,
A role for CBS domain 2 in trafficking of chloride channel CLC-5.
2003,
Pubmed Ceriotti,
mRNA translation in Xenopus oocytes.
1995,
Pubmed
,
Xenbase Christensen,
Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules.
2003,
Pubmed Cox,
Renal chloride channel, CLCN5, mutations in Dent's disease.
1999,
Pubmed DENT,
HYPERCALCURIC RICKETS ASSOCIATED WITH RENAL TUBULAR DAMAGE.
1964,
Pubmed Devuyst,
Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease.
1999,
Pubmed Dutzler,
Gating the selectivity filter in ClC chloride channels.
2003,
Pubmed
,
Xenbase Dutzler,
X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity.
2002,
Pubmed Fisher,
Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis).
1994,
Pubmed Fisher,
Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis).
1995,
Pubmed Friedrich,
Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents.
1999,
Pubmed
,
Xenbase Günther,
The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease.
2003,
Pubmed Günther,
ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells.
1998,
Pubmed Hansson,
A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity.
1995,
Pubmed
,
Xenbase Hebeisen,
The role of the carboxyl terminus in ClC chloride channel function.
2004,
Pubmed Hoopes,
Evidence for genetic heterogeneity in Dent's disease.
2004,
Pubmed Hoopes,
Dent Disease with mutations in OCRL1.
2005,
Pubmed Hryciw,
Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines.
2003,
Pubmed Igarashi,
Hypercalciuria and nephrocalcinosis in patients with idiopathic low-molecular-weight proteinuria in Japan: is the disease identical to Dent's disease in United Kingdom?
1995,
Pubmed Igarashi,
Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent'sJapan disease.
1998,
Pubmed
,
Xenbase Jentsch,
Chloride channels are different.
2002,
Pubmed Jentsch,
The CLC chloride channel family.
1999,
Pubmed Jouret,
Comparative ontogeny, processing, and segmental distribution of the renal chloride channel, ClC-5.
2004,
Pubmed Kemp,
Bateman domains and adenosine derivatives form a binding contract.
2004,
Pubmed Krieg,
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.
1984,
Pubmed
,
Xenbase Lloyd,
Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5).
1997,
Pubmed
,
Xenbase Lloyd,
A common molecular basis for three inherited kidney stone diseases.
1996,
Pubmed
,
Xenbase Lloyd,
Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders.
1997,
Pubmed
,
Xenbase Ludwig,
Four additional CLCN5 exons encode a widely expressed novel long CLC-5 isoform but fail to explain Dent's phenotype in patients without mutations in the short variant.
2003,
Pubmed Ludwig,
Dent disease-like phenotype and the chloride channel ClC-4 (CLCN4) gene.
2004,
Pubmed Ludwig,
Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene.
1998,
Pubmed Maduke,
Formation of CLC-0 chloride channels from separated transmembrane and cytoplasmic domains.
1998,
Pubmed
,
Xenbase Mo,
Coexpression of complementary fragments of ClC-5 and restoration of chloride channel function in a Dent's disease mutation.
2004,
Pubmed
,
Xenbase Morimoto,
Mutations in CLCN5 chloride channel in Japanese patients with low molecular weight proteinuria.
1998,
Pubmed
,
Xenbase Moulin,
Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patients.
2003,
Pubmed Nakazato,
Mutations in the CLCN5 gene in Japanese patients with familial idiopathic low-molecular-weight proteinuria.
1997,
Pubmed Piwon,
ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.
2000,
Pubmed Roth,
Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions.
2002,
Pubmed Scheinman,
X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations.
1998,
Pubmed Schwake,
An internalization signal in ClC-5, an endosomal Cl-channel mutated in dent's disease.
2001,
Pubmed
,
Xenbase Schwappach,
Golgi localization and functionally important domains in the NH2 and COOH terminus of the yeast CLC putative chloride channel Gef1p.
1998,
Pubmed Scott,
CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.
2004,
Pubmed Silva,
The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover.
2003,
Pubmed Snyder,
Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel.
1995,
Pubmed
,
Xenbase Staub,
WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome.
1996,
Pubmed Steinmeyer,
Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease.
1995,
Pubmed
,
Xenbase Takemura,
Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease).
2001,
Pubmed Wang,
Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.
2000,
Pubmed Wrong,
Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance.
1994,
Pubmed Wu,
Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship.
2003,
Pubmed Yamamoto,
Characterization of renal chloride channel (CLCN5) mutations in Dent's disease.
2000,
Pubmed
,
Xenbase Zerangue,
A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels.
1999,
Pubmed
,
Xenbase
